SMRxT, a medical information technology and services company, is relocating its corporate headquarters from New York to Orlando, Florida. The relocation is expected to create 55 new jobs and make a $582,000 capital investment to the region.

Mike Huffer, R.Ph. M.S. President/CEO of SMRxT, said, "We are extremely pleased with our decision to move SMRxT Inc. to Orlando. We have also relocated our medication bottle manufacturing from Virginia and have been able to reduce manufacturing costs by 40%. The Central Florida community has welcomed us with open arms and is the exact healthcare and technology hub we were looking for."

Governor Rick Scott said, “I am proud to announce today that SMRxT has chosen to relocate from New York to Florida and create 55 new jobs for Orlando families. We will keep working to diversify our economy by cutting $1 billion in taxes and creating a new $250 million Florida Enterprise Fund so we can attract more job creators to our state and make Florida first for jobs.”

The SMRxT corporate headquarters expansion was made possible through partnerships between Enterprise Florida, the Florida Department of Economic Opportunity, the Orlando Economic Development Commission, City of Orlando, and IQ Orlando, the new corporate partnership between Florida Hospital, UCF, Tavistock and the AHG Group.

“SMRxT’s inventive new technology expands on the recent growth of medical innovation in the region,” Rick Weddle, President/CEO of the Orlando Economic Development Commission said. “We are very excited to see the forward progression of this company and the positive impact it will have on the community.”

“Our vision is to grow Central Florida’s life science and healthcare cluster through a new corporate partnership that’s focused on launching, recruiting and funding companies that ultimately improve the health of the population, increase access and lower the cost of health care,” said Rick Wassel, Managing Director of IQ Orlando. “SMRxT, with its smart sensor and software technology, is pioneering medical products to reduce healthcare costs and improve individual health outcomes.”